2014
DOI: 10.1371/journal.pone.0091217
|View full text |Cite
|
Sign up to set email alerts
|

C/EBPβ Mediates Osteoclast Recruitment by Regulating Endothelial Progenitor Cell Expression of SDF-1α

Abstract: Integration of tissue-engineered bone grafts with the host bone is vital for the healing of critical-size bone defects. An important aspect of this process is bone resorption, which must be carried out by osteoclasts derived from the host. However, the mechanism underlying recruitment of host osteoclast precursors to graft sites remains unclear. Endothelial progenitor cells (EPCs) mobilize from the bone marrow into the circulation and home to sites of angiogenesis such as tissue remodeling. Since EPCs express … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
12
0

Year Published

2014
2014
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(13 citation statements)
references
References 51 publications
(63 reference statements)
1
12
0
Order By: Relevance
“…Other groups have previously shown the ability of S1P/S1PR agonism to promote the motility/migration of RAW264.7 cells, therefore, we set out to validate these findings using S1P (S1PR agonist), SEW2871 (S1PR1 agonist) and known monocyte chemotactic factor SDF-1α prior to performing our own studies (35). Indeed, we also demonstrate robust dose-dependent enhancement of RAW264.7 cell transwell migration with all three agents and thereby validated published data (Fig.…”
Section: Resultsmentioning
confidence: 82%
“…Other groups have previously shown the ability of S1P/S1PR agonism to promote the motility/migration of RAW264.7 cells, therefore, we set out to validate these findings using S1P (S1PR agonist), SEW2871 (S1PR1 agonist) and known monocyte chemotactic factor SDF-1α prior to performing our own studies (35). Indeed, we also demonstrate robust dose-dependent enhancement of RAW264.7 cell transwell migration with all three agents and thereby validated published data (Fig.…”
Section: Resultsmentioning
confidence: 82%
“…Evidences have shown that EPCs can secrete SDF‐1. Additionally, Fu, Pang, Xu, & Wu, observed that EPCs promote survival, migration, and differentiation of osteoclast precursors by producing VEGF A, SDF‐1, and transforming growth factor β1 (TGF‐β1) (Fu et al, ; Pang et al, ), which supports the role of SDF‐1 in the crosstalk between EPCs and osteoclasts. Meanwhile, it has been reported that irradiation elevated another chemokine CX3CL1 by vascular endothelium and stimulated osteoclastogenesis (Han et al, ).…”
Section: Discussionmentioning
confidence: 89%
“…They have also been reported to enhance osteogenic differentiation capacities of osteoblast precursors in vitro and in vivo [17,30]. With regard to the role of EPCs in osteoclast formation and function, previous reports have shown that EPCs support the survival, migration, and differentiation of RAW 264.7 cells, a model of osteoclastic monocyte precursors [19,20]. In this study, we found that EPCs derived from mouse umbilical cord blood promoted the proliferation, migration and osteoclastic differentiation of primary mouse BMMs in a EPC-BMM coculture system.…”
Section: Discussionmentioning
confidence: 98%
“…Emerging evidence suggests that EPCs may also play a role in osteoclast formation and function. Specifically, EPCs have been reported to support the survival, migration, and differentiation of RAW 264.7 cells, a model of osteoclastic monocyte precursors, through multiple signaling pathways [19,20]. However, whether EPCs can influence osteoclastogenesis by bone marrow-derived macrophages (BMMs) is not clear.…”
Section: Introductionmentioning
confidence: 99%